<i>HES4</i> is a potential biomarker for bladder cancer: a Mendelian randomization study.

J Cancer · 2024 · PMC10869984 · PMID 38370367

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

may be significantno p-value reported

We also identified AZD6482 as a potential drug for targeted treatment of BLCA, which may be significant for clinical decision-making in BLCA patients.

also in 13,097 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.